Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|5|3|196-208

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 196-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 11, 2015-02 ,pp. : 1472-1502

Bentham Science Publishers

Access to resources Recommend Favorite

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 439-452

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases

By Bonfils Claire   Walkinshaw Donald R   Besterman Jeffrey M   Yang Xiang-Jiao   Li Zuomei  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1041-1065

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 257-271

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)

By  

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 562-573

Bentham Science Publishers

Access to resources Recommend Favorite